Holen Sie sich die Stockscreener-App
113.85
2.51%
-2.93
Handel nachbörslich:
114.02
0.17
+0.15%
Icon Plc Aktie (ICLR) Neueste Nachrichten
ICON receives Nasdaq notice for delayed annual report filing - Investing.com
ICON Schedules Fourth Quarter and Full Year 2025 Earnings Conference Call and Acknowledges Receipt of Deficiency Notice from Nasdaq - Business Wire
Hybrid Clinical Research Job at ICON | Life Science Graduates Must Apply! - BioTecNika
ICON Plc (ICLR) Stock Analysis: Unveiling A 13.55% Upside Potential For Investors - DirectorsTalk Interviews
How Icon Plc (ICLR) Affects Rotational Strategy Timing - Stock Traders Daily
ICON earnings ahead: First results since accounting probe ends By Investing.com - Investing.com India
ICON earnings ahead: First results since accounting probe ends - Investing.com
Hybrid Clinical Research Associate Job at ICON plc | Apply Now - BioTecNika
ICON expands US early phase research capabilities with new clinic and outpatient centres - MSN
ICLR Stock Price, Quote & Chart | ICON PLC (NASDAQ:ICLR) - ChartMill
ICON plc stock (IE0005711209): clinical research specialist with fresh earnings in focus - AD HOC NEWS
ICON plc options imply 9.7% move in share price post-earnings - TipRanks
Templeton World Fund's Icon PLC(ICLR) Holding History - GuruFocus
ICON stock (IE0005711209): how the clinical research specialist is navigating post-pandemic demand - AD HOC NEWS
J.P. Morgan Maintains Icon PLC(ICLR.US) With Hold Rating, Cuts Target Price to $120 - Moomoo
ICLR SEC FilingsICON PLC 10-K, 10-Q, 8-K Forms - Stock Titan
Manhattan West Asset Management, LLC's Icon PLC(ICLR) Holding History - GuruFocus
Icon (ICLR) Receives Sector Perform Rating from RBC Capital - GuruFocus
Icon Set to Benefit From Rising Clinical Trial Activity, Strong Relationships With Large Pharma, RBC Says - Moomoo
Icon Is Maintained at Neutral by JP Morgan - Moomoo
Icon Price Target Announced at $123.00/Share by RBC Capital - Moomoo
RBC Capital resumes ICON stock coverage citing trial activity By Investing.com - Investing.com Australia
RBC Capital Initiates Icon PLC(ICLR.US) With Hold Rating, Announces Target Price $123 - 富途牛牛
ICON plc stock (IE0005711209): clinical research specialist after solid Q1 update - AD HOC NEWS
ICLR Purchasers Have Opportunity to Lead ICON plc Securities Fra - GuruFocus
Harris Associates L.P. discloses 5.7% stake in ICON plc (ICLR) - Stock Titan
Orbis, Allan Gray file Schedule 13G/A for ICON PLC (ICLR) reporting 0 shares - Stock Titan
ICON PLC (NASDAQ: ICLR) director logs 5,005-option expiration extension - Stock Titan
ICON PLC (ICLR) director logs mixed transactions on 5,005 stock options - Stock Titan
ICON PLC (ICLR) director reshapes 3,255 stock options in Form 4 - Stock Titan
Wellington entities report 7.74% stake in Icon (ICLR) - Stock Titan
Icon Opens New Clinical Facilities in Move to Expand Early-Phase Capabilities - Moomoo
ICON plc stock (IE0005711209): Expands early-phase research with new Texas clinic - AD HOC NEWS
ICON opens new Texas clinical research unit - BioXconomy
ICON (ICLR) Expands Early Phase Capabilities with New Facilities - GuruFocus
A Look at Icon PLC (ICLR) After 3.7% Decline -- GF Value $241.78 vs Price $117.38 - GuruFocus
Icon announces new Clinical Research Unit in San Antonio, Texas - TipRanks
Icon Expands Early Phase Capabilities - Contract Pharma
ICON's New Texas Hub Aims to Reshape Early Phase Drug Trials - BriefGlance
Templeton Growth Fund, Inc.'s Icon PLC(ICLR) Holding History - GuruFocus
Does ICON (ICLR)ʼs 20‑F Delay Reshape the Narrative Around Its Strong Institutional Ownership Base? - Sahm
A Look at Icon PLC (ICLR) After 4.7% Decline -- GF Value $241.81 vs Price $118.96 - GuruFocus
Icon Plc $ICLR Shares Sold by Truist Financial Corp - MarketBeat
ICON earnings on deck: Can CRO move past accounting cloud? - Investing.com UK
1.19%
0.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):